In Vitro Diagnostics Market Outlook 2028

  • The global in vitro diagnostics market was valued at US$ 70.51 Bn in 2020
  • It is estimated to expand at a CAGR of 6.3% from 2021 to 2028
  • The global in vitro diagnostics market is expected to reach the value of US$ 115.43 Bn by the end of 2028

Analysts’ Viewpoint on In Vitro Diagnostics Market Scenario

The ongoing COVID-19 pandemic has created an unprecedented demand for molecular and antigen tests. Apart from the discovery of new forms of tumors in the human body, the high rate of morbidity & mortality for known tumors among the masses has transcended as a challenge for the healthcare sector. Hence, market stakeholders should collaborate with researchers to improve early detection of tumors in order to reduce morbidity & mortality of patients. Moreover, the increase in global health care expenditure, owing to the rise in disposable income is expected to propel the growth of the market for in vitro diagnostics. Rise in the healthcare expenditure due to the increase in awareness about various healthcare programs and availability of cost-effective diagnostic methods are likely to augment the growth of the global in vitro diagnostics market.

In Vitro Diagnostics Provides Appropriate Therapeutic Regimes for Patients

New innovative technologies such as RT-PCR (Reverse Transcription – Polymerase Chain Reaction) and next generation sequencing provide a comparatively less expensive way of diagnosis, prognosis, and therapy selection in patients throughout their treatment plan. This helps physicians frame appropriate therapeutic regimes for patients suffering from diseases. Such trends are contributing to the growth of the in vitro diagnostics market. The rise in demand for point-of-care (POC) services is likely to drive the in vitro diagnostics market. Point-of-care provides quick and accurate results compared to traditional methods.

In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases. In vitro diagnostics could also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.

Request a sample to get extensive insights into the In Vitro Diagnostics Market

Ongoing Prevalence of COVID-19 Fueling Demand for In-vitro Diagnostic Tests

The rising incidence of infectious diseases is playing an important role in growth of the in vitro diagnostics market. The outbreak of the COVID-19 pandemic has led to investments in new research lines for diagnostics and treatment of infectious diseases. The medical industry has tasted some success in developing resilient diagnostic technologies for COVID-19. However, there is a long way ahead for the medical and healthcare sectors.

As new research lines emerge for the management of the pandemic, the global in-vitro diagnostics market would grow at a steady pace. Furthermore, there has been an increase in the number of cases for COVID-19 and its variants. This factor has also played an underhanded role in driving demand for in vitro diagnostic tests. The analysis of blood samples has gained relevance across several verticals of the healthcare sector.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Rising Incidence of Various Communicable and Non-communicable Diseases Catalyzing Market Growth

The use of in vitro testing in North America has increased by a noticeable pace. This can be attributed to the steep rise in the number of COVID-19 cases across the U.S. Several Asia Pacific countries have also joined hands to deal with the rising incidence of various communicable and non-communicable diseases. This has given an impetus to the growth of the Asia Pacific in vitro diagnostics market. The marked rise in the number of cases of cancer and lung disorders is likely to aid in market expansion in several regions.

The vendors operating in the global in vitro diagnostics market are making deliberate efforts to educate people about the relevance of testing and sample collection. The quest of these vendors to capture new domains within the domain of healthcare is expected to drive demand within the global market.

Stuck in a neck-to-neck competition with other brands? Request a custom report on In Vitro Diagnostics Market

Ever-changing Oncology Landscape Challenging Healthcare Sector

Companies in the in vitro diagnostics market are increasing R&D in testing of infectious diseases, drug testing, oncology, autoimmune diseases, and metabolic diseases, among others. The unprecedented demand for improved diagnostics in the field of oncology is anticipated to drive the demand within the market. In addition, the discovery of new forms of tumors in the human body has raised concerns across the healthcare sector.

Besides, the rising occurrence of known tumors among the masses has transcended as a challenge for the healthcare sector. Therefore, the quest of the healthcare industry to resolve the growing incidence of various types of cancers is projected to fuel the growth of the global in vitro diagnostics market. Furthermore, the collection of samples for biopsies and other similar tests has also supported market maturity. The next few years would be crucial in understanding the direction of growth for the in vitro diagnostics market. The revolutionary growth of the diagnostics domain could prove to be a game changer for market vendors.

In Vitro Diagnostics Market: Overview

  • In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body
  • In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases
  • In vitro diagnostics can also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies
  • These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations

Improved Purchasing Power: Key Driver

  • Increase in global health care expenditure, owing to rise in disposable income is expected to propel the global in vitro diagnostics market
  • Rise in health care expenditure due to increase in awareness about various health care programs and availability of cost-effective diagnostic methods are likely to augment the global in vitro diagnostics market

Rise in Demand for Innovative Technologies: Major Driver

  • New innovative technologies such as RT-PCR and next generation sequencing provide a comparatively less expensive way of diagnosis, prognosis, and therapy selection in patients throughout their treatment plan. This helps physicians frame appropriate therapeutic regimes for patients suffering from diseases.
  • Rise in demand for point-of-care services is likely to drive the in vitro diagnostics market. Point-of-care provides quick and accurate results compared to traditional methods.

Infectious Diseases Segment to Dominate Global In Vitro Diagnostics Market

  • In terms of application, the global in vitro diagnostics market has been classified into drug testing, infectious diseases, oncology, metabolic diseases, autoimmune diseases, and others
  • The infectious diseases segment dominated the global market in terms of share in 2020
  • Rise in prevalence of infectious diseases is projected to open up new avenues for in vitro diagnostics during the forecast period
  • Surge in demand for rapid diagnostic techniques due to slow turnaround time of current techniques, high prevalence of infectious diseases, and rise in government funding drive the infectious diseases segment

North America to Lead Global In Vitro Diagnostics Market

  • In terms of region, the global in vitro diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is anticipated to dominate the global market during the forecast period, accounting for 38.40% share by 2028. The market in the region is expected to reach US$ 44.33 Bn by 2028.
  • The U.S. dominated the market in North America in 2020 due to adoption of new technologies such as next generation sequencing, higher awareness, significant health care spending in overall national budgets, early availability of advanced technologies, and higher penetration of research activities across the country

Major Players

  • Key players operating in the global in vitro diagnostics market include
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Siemens Healthineers
    • bioMérieux SA
    • Abbott
    • Diasorin
    • Meridian Bioscience, Inc.
    • Ortho-Clinical Diagnostics, Inc.
    • Thermo Fisher Scientific, Inc.
    • Sysmex Corporation
  • Each of these players has been profiled in the in vitro diagnostics market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

In Vitro Diagnostics Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 70.51 Bn

Market Forecast Value in 2028

US$ 115.43 Bn

Growth Rate (CAGR)

6.3%

Forecast Period

2017–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Technology Type
    • Point-of-Care
    • Molecular Diagnostics
    • Immunoassays
    • Clinical Chemistry
    • Whole Blood Glucose Monitoring
    • Hematology
    • Clinical Microbiology
    • Coagulation & Hemostasis
    • Others
  • Application
    • Drug Testing
    • Infectious Diseases
    • Oncology
    • Metabolic Diseases
    • Autoimmune Diseases
    • Others
  • End-user
    • Diagnostic Laboratories
    • Hospitals
    • Academic & Research Centers
    • Home Care
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

In Vitro Diagnostics Market – Segmentation

TMR’s study on the global in vitro diagnostics market includes information divided into four segments: technology type, application, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global in vitro diagnostics market are discussed in detail.

Technology Type
  • Point-of-Care
  • Molecular Diagnostics
  • Immunoassays
  • Clinical Chemistry
  • Whole Blood Glucose Monitoring
  • Hematology
  • Clinical Microbiology
  • Coagulation & Hemostasis
  • Others
Application
  • Drug Testing
  • Infectious Diseases
  • Oncology
  • Metabolic Diseases
  • Autoimmune Diseases
  • Others
End-user
  • Diagnostic Laboratories
  • Hospitals
  • Academic & Research Centers
  • Home Care
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global in vitro diagnostics market was worth US$ 70.51 Bn and is projected to reach a value of US$ 115.43 Bn by the end of 2028

In vitro diagnostics market is anticipated to grow at a CAGR of 6.3% during the forecast period

North America accounted for a major share of the global in vitro diagnostics market

In vitro diagnostics market is driven by rise in prevalence of these infectious diseases is likely to increase the demand for diagnostic tests, which in turn is projected to propel the global market

Key players in the global in vitro diagnostics market include F. Hoffmann-La Roche Ltd., Danaher, Siemens Healthineers, bioMérieux SA, Abbott, Diasorin, Meridian Bioscience, Inc., Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., and Sysmex Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In Vitro Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Application Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global In Vitro Diagnostics Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Mergers and Acquisition

    5.2. Key Success Factor for Top 3 Players

    5.3. Regulatory Scenario

    5.4. Technology Assessment

6. Global In Vitro Diagnostics Market Analysis and Forecast, by Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Application, 2017–2028

        6.3.1. Drug Testing

        6.3.2. Infectious Diseases

        6.3.3. Oncology

        6.3.4. Metabolic Diseases

        6.3.5. Autoimmune Diseases

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Application

7. Global In Vitro Diagnostics Market Analysis and Forecast, by End-user  

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by End-user, 2017–2028

        7.3.1. Diagnostic Laboratories

        7.3.2. Hospitals

        7.3.3. Academic & Research Centers

        7.3.4. Home Care

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by End-user  

8. Global In Vitro Diagnostics Market Analysis and Forecast, by Technology Type

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value & Volume Forecast, by Technology Type, 2017–2028

        8.3.1. Point-of-care

        8.3.2. Molecular Diagnostics

        8.3.3. Immunoassays

        8.3.4. Clinical Chemistry

        8.3.5. Whole Blood Glucose Monitoring

        8.3.6. Hematology

        8.3.7. Clinical Microbiology

        8.3.8. Coagulation & Hemostasis

        8.3.9. Others

    8.4. Market Attractiveness Analysis, by Technology Type

9. Global In Vitro Diagnostics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value & Volume Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America In Vitro Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Application, 2017–2028

        10.2.1. Drug Testing

        10.2.2. Infectious Diseases

        10.2.3. Oncology

        10.2.4. Metabolic Diseases

        10.2.5. Autoimmune Diseases

        10.2.6. Others

    10.3. Market Value & Volume Forecast, by End-user, 2017–2028

        10.3.1. Diagnostic Laboratories

        10.3.2. Hospitals

        10.3.3. Academic & Research Centers

        10.3.4. Home Care

        10.3.5. Others

    10.4. Market Value & Volume Forecast, by Technology Type, 2017–2028

        10.4.1. Point-of-care

        10.4.2. Molecular Diagnostics

        10.4.3. Immunoassays

        10.4.4. Clinical Chemistry

        10.4.5. Whole Blood Glucose Monitoring

        10.4.6. Hematology

        10.4.7. Clinical Microbiology

        10.4.8. Coagulation & Hemostasis

        10.4.9. Others

    10.5. Market Value & Volume Forecast, by Country, 2017–2028

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Application

        10.6.2. By End-user  

        10.6.3. By Technology Type

        10.6.4. By Country

11. Europe In Vitro Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Application, 2017–2028

        11.2.1. Drug Testing

        11.2.2. Infectious Diseases

        11.2.3. Oncology

        11.2.4. Metabolic Diseases

        11.2.5. Autoimmune Diseases

        11.2.6. Others

    11.3. Market Value & Volume Forecast, by End-user, 2017–2028

        11.3.1. Diagnostic Laboratories

        11.3.2. Hospitals

        11.3.3. Academic & Research Centers

        11.3.4. Home Care

        11.3.5. Others

    11.4. Market Value & Volume Forecast, by Technology Type, 2017–2028

        11.4.1. Point-of-care

        11.4.2. Molecular Diagnostics

        11.4.3. Immunoassays

        11.4.4. Clinical Chemistry

        11.4.5. Whole Blood Glucose Monitoring

        11.4.6. Hematology

        11.4.7. Clinical Microbiology

        11.4.8. Coagulation & Hemostasis

        11.4.9. Others

    11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Application

        11.6.2. By End-user  

        11.6.3. By Technology Type

        11.6.4. By Country/Sub-region

12. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Application, 2017–2028

        12.2.1. Drug Testing

        12.2.2. Infectious Diseases

        12.2.3. Oncology

        12.2.4. Metabolic Diseases

        12.2.5. Autoimmune Diseases

        12.2.6. Others

    12.3. Market Value & Volume Forecast, by End-user, 2017–2028

        12.3.1. Diagnostic Laboratories

        12.3.2. Hospitals

        12.3.3. Academic & Research Centers

        12.3.4. Home Care

        12.3.5. Others

    12.4. Market Value & Volume Forecast, by Technology Type, 2017–2028

        12.4.1. Point-of-care

        12.4.2. Molecular Diagnostics

        12.4.3. Immunoassays

        12.4.4. Clinical Chemistry

        12.4.5. Whole Blood Glucose Monitoring

        12.4.6. Hematology

        12.4.7. Clinical Microbiology

        12.4.8. Coagulation & Hemostasis

        12.4.9. Others

    12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Application

        12.6.2. By End-user  

        12.6.3. By Technology Type

        12.6.4. By Country/Sub-region

13. Latin America In Vitro Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Application, 2017–2028

        13.2.1. Drug Testing

        13.2.2. Infectious Diseases

        13.2.3. Oncology

        13.2.4. Metabolic Diseases

        13.2.5. Autoimmune Diseases

        13.2.6. Others

    13.3. Market Value & Volume Forecast, by End-user, 2017–2028

        13.3.1. Diagnostic Laboratories

        13.3.2. Hospitals

        13.3.3. Academic & Research Centers

        13.3.4. Home Care

        13.3.5. Others

    13.4. Market Value & Volume Forecast, by Technology Type, 2017–2028

        13.4.1. Point-of-care

        13.4.2. Molecular Diagnostics

        13.4.3. Immunoassays

        13.4.4. Clinical Chemistry

        13.4.5. Whole Blood Glucose Monitoring

        13.4.6. Hematology

        13.4.7. Clinical Microbiology

        13.4.8. Coagulation & Hemostasis

        13.4.9. Others

    13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Application

        13.6.2. By End-user  

        13.6.3. By Technology Type

        13.6.4. By Country/Sub-region

14. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value & Volume Forecast, by Application, 2017–2028

        14.2.1. Drug Testing

        14.2.2. Infectious Diseases

        14.2.3. Oncology

        14.2.4. Metabolic Diseases

        14.2.5. Autoimmune Diseases

        14.2.6. Others

    14.3. Market Value & Volume Forecast, by End-user, 2017–2028

        14.3.1. Diagnostic Laboratories

        14.3.2. Hospitals

        14.3.3. Academic & Research Centers

        14.3.4. Home Care

        14.3.5. Others

    14.4. Market Value & Volume Forecast, by Technology Type, 2017–2028

        14.4.1. Point-of-care

        14.4.2. Molecular Diagnostics

        14.4.3. Immunoassays

        14.4.4. Clinical Chemistry

        14.4.5. Whole Blood Glucose Monitoring

        14.4.6. Hematology

        14.4.7. Clinical Microbiology

        14.4.8. Coagulation & Hemostasis

        14.4.9. Others

    14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Application

        14.6.2. By End-user  

        14.6.3. By Technology Type

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Market Footprint Analysis

        15.3.1. By Region

        15.3.2. By Application Type

    15.4. Competitive Business Strategies

    15.5. Company Profiles

        15.5.1. Competition Matrix

            15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.1.2. Product Portfolio

            15.5.1.3. SWOT Analysis

            15.5.1.4. Strategic Overview

        15.5.2. F. Hoffmann-La Roche Ltd.

            15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.2.2. Product Portfolio

            15.5.2.3. SWOT Analysis

            15.5.2.4. Strategic Overview

        15.5.3. Danaher

            15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.3.2. Product Portfolio

            15.5.3.3. SWOT Analysis

            15.5.3.4. Strategic Overview

        15.5.4. Siemens Healthineers

            15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.4.2. Product Portfolio

            15.5.4.3. SWOT Analysis

            15.5.4.4. Strategic Overview

        15.5.5. bioMérieux SA

            15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.5.2. Product Portfolio

            15.5.5.3. SWOT Analysis

            15.5.5.4. Strategic Overview

        15.5.6. Abbott

            15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.6.2. Product Portfolio

            15.5.6.3. SWOT Analysis

            15.5.6.4. Strategic Overview

        15.5.7. Diasorin

            15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.7.2. Product Portfolio

            15.5.7.3. SWOT Analysis

            15.5.7.4. Strategic Overview

        15.5.8. Meridian Bioscience, Inc.

            15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.8.2. Product Portfolio

            15.5.8.3. SWOT Analysis

            15.5.8.4. Strategic Overview

        15.5.9. Ortho-Clinical Diagnostics, Inc.

            15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.9.2. Product Portfolio

            15.5.9.3. SWOT Analysis

            15.5.9.4. Strategic Overview

        15.5.10. Thermo Fisher Scientific, Inc.

            15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.10.2. Product Portfolio

            15.5.10.3. SWOT Analysis

            15.5.10.4. Strategic Overview

        15.5.11. Sysmex Corporation

            15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.11.2. Product Portfolio

            15.5.11.3. SWOT Analysis

            15.5.11.4. Strategic Overview

        15.5.12. Other Prominent Players

            15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.12.2. Product Portfolio

            15.5.12.3. SWOT Analysis

            15.5.12.4. Strategic Overview

List of Table

Table 01: Global In Vitro Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Technology Type, 2021–2028

Table 02: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 03: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 04: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 05: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Application, 2021–2028

Table 06: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 07: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Region, 2021–2028

Table 08: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country 2021–2028

Table 09: North America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 10: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 11: America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 12: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 13: North America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 14: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 15: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 16: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 17: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 18: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 19: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 20: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 21: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 22: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 23: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 24: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 25: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 26: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 27: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 28: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 29: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 30: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 31: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 32: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 33: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 34: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 35: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 36: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 37: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 38: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 39: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 40: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 41: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 42: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

List of Figures

Figure 01: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, 2021–2028

Figure 02: Global In Vitro Diagnostics Market Value Share Analysis by Technology Type, 2021 and 2028

Figure 03: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Point-of-Care, 2017–2028

Figure 04: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Molecular Diagnostics, 2017–2028

Figure 05: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Immunoassays, 2017–2028

Figure 06: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Clinical Chemistry, 2017–2028

Figure 07: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Whole Blood Glucose Monitoring, 2017–2028

Figure 08: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Hematology, 2017–2028

Figure 09: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Clinical Microbiology, 2017–2028

Figure 10: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Coagulation & Hemostasis, 2017–2028

Figure 11: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028

Figure 12: Global In Vitro Diagnostics Market Attractiveness Analysis, by Technology Type, 2021-2028

Figure 13: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 14: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Drug Testing, 2017–2028

Figure 15: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Infectious Diseases, 2017–2028

Figure 16: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Oncology, 2017–2028

Figure 17: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Metabolic Diseases, 2017–2028

Figure 18: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Autoimmune Diseases, 2017–2028

Figure 19: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028

Figure 20: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028

Figure 21: Global In Vitro Diagnostics Market Value Share Analysis by End-user, 2021 and 2028

Figure 22: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratories, 2017–2028

Figure 23: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2028

Figure 24: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Academic & Research Centers, 2017–2028

Figure 25: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Home Care, 2017–2028

Figure 26: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028

Figure 27: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028

Figure 28: Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2021 and 2028

Figure 29: Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2021-2028

Figure 30: North America In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 31: North America In Vitro Market Attractiveness Analysis, by Country, 2021–2028

Figure 32: North America Market Value Share Analysis, by Country, 2021 and 2028

Figure 33: North America In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028

Figure 34: North America In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 35: North America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028

Figure 36: Europe In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 37: Europe In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028

Figure 38: Europe Market Value Share Analysis by Country/Region, 2021 and 2028

Figure 39: Europe In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028

Figure 40: Europe In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 41: Europe In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028

Figure 42: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 43: Asia Pacific In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028

Figure 44: Asia Pacific Market Value Share Analysis by Country/Region, 2021 and 2028

Figure 45: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028

Figure 46: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 47: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028

Figure 48: Latin America In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 49: Latin America In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028

Figure 50: Latin America Market Value Share Analysis by Country/Region, 2021 and 2028

Figure 51: Latin America In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028

Figure 52: Latin America In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 53: Latin America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028

Figure 54: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 55: Middle East & Africa In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028

Figure 56: Middle East & Africa Market Value Share Analysis by Country/Region, 2021 and 2028

Figure 57: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028

Figure 58: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028

Figure 59: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028

Figure 60: Global In Vitro Diagnostics Market Share Analysis, by Company, 2020

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

In Vitro Diagnostics Market